Back

Enterobactin and Salmochelin S4 inhibit the growth of Staphylococcus aureus

Davidov, Y.; Tejman-Yarden, N.; Robinson, A.; Rahav, G.; Nissan, I.

2024-06-30 microbiology
10.1101/2024.06.30.601405 bioRxiv
Show abstract

There is increasing demand for novel antimicrobial agents to tackle the antimicrobial resistance crisis. Here we report that two Enterobacteriaceae-produced siderophores, enterobactin and salmochelin S4, inhibit the growth of Staphylococcus aureus isolates, including methicillin-resistance S. aureus (MRSA) clinical isolates. The MIC50 for different S. aureus isolates were 2-5 M for salmochelin S4 and 5-10 M for enterobactin. This inhibitory activity was partially repressed by adding Fe+3. These siderophores also inhibited the growth of Enterococcus strains, including vancomycin-resistant enterococci (VRE) clinical isolates, though less effectively than for S. aureus. The growth of various Gram-negative bacteria was barely affected by these siderophores. These results shed new light on the role of enterobactin and salmochelin in bacterial physiology and ecology and have potential for the development of novel strategies to combat the rapid rise of multidrug-resistant bacteria.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Frontiers in Microbiology
○ 427 papers in training set
Top 0.3%
14.9%
Similar papers in this journal
2
Microbiology Spectrum
● 469 papers in training set
Top 0.9%
9.7%
Similar papers in this journal
3
Antibiotics
○ 34 papers in training set
Top 0.1%
9.6%
Similar papers in this journal
4
Applied and Environmental Microbiology
● 339 papers in training set
Top 1%
6.2%
Similar papers in this journal
5
Microbiology
● 65 papers in training set
Top 0.2%
5.1%
Similar papers in this journal
6
Antimicrobial Agents and Chemotherapy
● 187 papers in training set
Top 0.8%
3.2%
7
MicrobiologyOpen
○ 24 papers in training set
Top 0.1%
3.2%
50% of probability mass above
8
eLife
● 5828 papers in training set
Top 36%
3.2%
9
Journal of Global Antimicrobial Resistance
○ 17 papers in training set
Top 0.2%
3.1%
10
Microbial Biotechnology
○ 34 papers in training set
Top 0.2%
2.8%
11
Journal of Applied Microbiology
◐ 20 papers in training set
Top 0.2%
2.7%
12
Scientific Reports
○ 3612 papers in training set
Top 41%
2.4%
13
mBio
● 833 papers in training set
Top 6%
2.4%
14
Frontiers in Cellular and Infection Microbiology
○ 109 papers in training set
Top 1%
2.4%
15
Journal of Antimicrobial Chemotherapy
◐ 46 papers in training set
Top 0.5%
2.1%
16
Molecular Microbiology
○ 77 papers in training set
Top 0.7%
1.7%
17
ACS Infectious Diseases
● 82 papers in training set
Top 0.8%
1.7%
18
mSphere
● 302 papers in training set
Top 5%
1.3%
19
Microorganisms
○ 106 papers in training set
Top 3%
1.1%
20
FEMS Microbiology Letters
◐ 17 papers in training set
Top 0.2%
1.1%
21
Environmental Microbiology
○ 133 papers in training set
Top 2%
1.1%
22
PLOS ONE
● 5266 papers in training set
Top 53%
1.1%
23
npj Antimicrobials and Resistance
○ 11 papers in training set
Top 0.1%
1.1%
24
iScience
○ 1154 papers in training set
Top 31%
1.0%
25
Biochimie
○ 25 papers in training set
Top 0.8%
0.8%
26
Nature Communications
○ 5641 papers in training set
Top 56%
0.8%
27
Environmental Pollution
○ 37 papers in training set
Top 1%
0.6%
28
Frontiers in Medicine
○ 120 papers in training set
Top 5%
0.6%
29
The Journal of Infectious Diseases
◐ 202 papers in training set
Top 4%
0.6%
30
Infection and Immunity
● 120 papers in training set
Top 2%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.